Newsletter Subject

Senators Discuss Making Medicare's Relaxed Telehealth Rules Permanent

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Wed, Nov 15, 2023 11:52 PM

Email Preheader Text

Daily Headlines Wednesday, November 15, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTL

[MEDPAGE TODAY]( Daily Headlines Wednesday, November 15, 2023 Today's Top Stories for {NAME} [PRACTICE MANAGEMENT]( [Senators Discuss Making Medicare's Relaxed Telehealth Rules Permanent]( [ENDOCRINOLOGY]( [Even Small Diabetes Distress Changes Clinically Important]( [NEUROLOGY]( [Hippocampal Atrophy Tied to Cognitive Decline]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Emerging Evidence in the Treatment of Chronic Lymphocytic Leukemia]( [NEUROLOGY]( [Gantenerumab Failed to Slow Cognitive Decline in Early Alzheimer's]( [ENDOCRINOLOGY]( [One Copeptin Test More Accurate as Diagnostic for AVP Deficiency]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [THE BREAK ROOM]( [Spell Check-Up: Try to Pass This Spelling Quiz]( CME SPOTLIGHT [Advancing Care of Patients With Sickle Cell Disease]( [SPECIAL REPORTS]( [Health Officer May Get $4M to Step Down]( [MEETING COVERAGE]( [PPAR Agonist Led to 'Clinically Meaningful' Improvement in PBC-Related Pruritus]( [MEETING COVERAGE]( ['We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma]( CME SPOTLIGHT [Uncovering the Under-Diagnosed in MDS: The MDS Diagnostic Accelerator Hub]( [MEETING COVERAGE]( [Novel MASH Drug Reduces Liver Fat in Mid-Stage Trial]( [CLINICAL CHALLENGES]( [Clinical Challenges: Managing Toxicities of Newer Breast Cancer Therapies]( [NEPHROLOGY]( [FDA OKs Product to Thwart Bloodstream Infections During Dialysis]( CME SPOTLIGHT [Expanding Evaluation and Referral of Anemia in Primary Care Settings to Diagnose Underlying Myelodysplastic Syndromes]( [PSYCHIATRY]( [Suicide Rates High in Older Men; Novel Ketamine Pill; SSRIs' Sexual Side Effects]( [OPINION]( [Invasive Mental Health Questions Have No Place on Nurse Licensing Applications]( [CLINICAL CHALLENGES]( [Clinical Challenges: Test Your Knowledge on Atopic Dermatitis]( CME SPOTLIGHT [Improving Access to Quality Evidence-Based Care for Acute Myeloid Leukemia]( [CLINICAL CHALLENGES]( [Clinical Challenges: Atopic Dermatitis in Infants]( [MEETING COVERAGE]( [Added Leukotriene Receptor Antagonists Show Benefits in Chronic Urticaria]( [OPHTHALMOLOGY]( [Study Outlines the Considerable Costs of Keratoconus]( CME SPOTLIGHT [Advancing AML Care: A Targeted Approach]( [CARDIOLOGY]( [Alleged Stroke Trial Misconduct; Ultrasound Tx for Severe AS; Farxiga's eGFR Drops]( [MEETING COVERAGE]( [CAR T-Cell Approach to Autoimmune Disease Gains Traction]( [INFECTIOUS DISEASE]( [COVID Rebound May Occur in 20% of Paxlovid Users]( [MEETING COVERAGE]( [AMA Delegates Spar Over Requirements for On-Site Emergency Physicians in Every ED]( [AAD READING ROOM]( [Clascoterone Cream in Patients With Acne: New Long-Term Data]( [CLINICAL CHALLENGES]( [Clinical Challenges: Approaches to Managing Steatotic Liver Disease]( # Weekly Survey [Drop Medicare Patients If Pay Cut Goes Through?]( Physicians will face a [3.4% cut in payments]( for their Medicare patients in 2024 unless Congress intervenes[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-11-15&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.